Accordingly, in this study, we created the RNA‐sequencing‐based miRNA expression signature of BrCa using clinical BrCa specimens, including ER‐positive, HER2‐positive, and TNBC specimens. This evidence concerns the gene ERBB2 and invasive breast carcinoma.